Signet ring cell adenocarcinoma of the lung with an EML4-ALK fusion gene mimicking mucinous (colloid) adenocarcinoma: A case report

Lung Cancer

Volumn 73, Issue 3, 2011, Pages 375-378

  Ohba, Taro ^a   Sugio, Kenji ^a   Kometani, Takuro ^a   Yamaguchi, Masafumi ^a   Hamatake, Motoharu ^a   Nosaki, Kaname ^a   Takeoka, Hiroaki ^a   Kitajima, Hiromoto ^a   Hirai, Fumihiko ^a   Seto, Takashi ^a   Taguchi, Kenichi ^a   Nishiyama, Kenichi ^a   Shida, Yoshitaka ^a   Ichinose, Yukito ^a  

^a NATIONAL KYUSHU CANCER CENTER   (Japan)

Author keywords

EML4 ALK; Histopathology; Multiplex RT PCR; Non small cell lung cancer; Signet ring cell carcinoma; Surgery

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; CARCINOEMBRYONIC ANTIGEN; ECHINODERM MICROTUBULE ASSOCIATED PROTEIN LIKE 4 ANAPLASTIC LYMPHOMA KINASE; FLUORODEOXYGLUCOSE F 18; MICROTUBULE ASSOCIATED PROTEIN 4; MUCIN; ONCOPROTEIN; UNCLASSIFIED DRUG;

ADENOCARCINOMA; AGED; ARTICLE; CANCER SCREENING; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FROZEN SECTION; FUSION GENE; HUMAN; IMMUNOHISTOCHEMISTRY; LOBECTOMY; LUNG ADENOCARCINOMA; LUNG TUMOR; LYMPH NODE DISSECTION; MEDIASTINUM TUMOR; MUCINOUS ADENOCARCINOMA; MULTIPLEX POLYMERASE CHAIN REACTION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNET RING CARCINOMA; THORAX PAIN; THORAX RADIOGRAPHY;

ADENOCARCINOMA, MUCINOUS; AGED; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, SIGNET RING CELL; CHEST PAIN; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; ONCOGENE PROTEINS, FUSION; PNEUMONECTOMY;

EID: 79960894408     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2011.05.016     Document Type: Article

References (14)

1. Travis W.D., Brambilla E., Muller-Hermelink H.K., Harris C.C. World health organization classification of tumors: pathology and genetics of tumors of the lung, pleural thymus and hert 2004, IARC Press, Lyon, France.
2. Rossi G., Murer B., Cavazza A., Losi L., Natali P., Marchioni A., et al. Primary mucinous (so-called colloid) carcinomas of the lung: a clinicopathologic and immunohistochemical study with special reference to CDX-2 homeobox gene and MUC2 expression. Am J Surg Pathol 2004, 28:442-452.
3. Travis W.D., Brambilla E., Noguchi M., Nicholson A.G., Geisinger K.R., Yatabe Y., et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011, 6:244-285.
4. Soda M, Choi Y.L., Enomoto M., Takada S., Yamashita Y., Ishikawa S., et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 2007, 448:561-566.
5. Chiarle R., Voena C., Ambrogio C., Piva R., Inghirami G. The anaplastic lymphoma kinase in the pathogenesis of cancer. Nat Rev Cancer 2008, 8:11-23.
6. Shaw A.T., Yeap B.Y., Mino-Kenudson M., Digumarthy S.R., Costa D.B., Heist R.S., et al. Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK. J Clin Oncol 2009, 27:4247-4253.
7. Inamura K., Takeuchi K., Togashi Y., Hatano S., Ninomiya H., Motoi N., et al. EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset. Mod Pathol 2009, 22:508-515.
8. Takeuchi K., Choi Y.L., Soda M., Inamura K., Togashi Y., Hatano S., et al. Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts. Clin Cancer Res 2008, 14:6618-6624.
9. Tsuta K., Ishii G., Nitadori J., Murata Y., Kodama T., Nagai K., et al. Comparison of the immunophenotypes of signet-ring cell carcinoma, solid adenocarcinoma with mucin production, and mucinous bronchioloalveolar-carcinoma of the lung characterized by the presence of cytoplasmic mucin. J Pathol 2006, 209:78-87.
10. Lynch T.J., Bell D.W., Sordella R., Gurubhagavatula S., Okimoto R.A., Brannigan B.W., et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004, 350:2129-2139.
11. Paez J.G., Janne P.A., Lee J.C., Tracy S., Greulich H., Gabriel S., et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004, 304:1497-1500.
12. Sugio K., Uramoto H., Ono K., Oyama T., Hanagiri T., Sugaya M., et al. Mutations within the tyrosine kinase domain of EGFR gene specifically occur in lung adenocarcinoma patients with a low exposure of tobacco smoking. Br J Cancer 2006, 94:896-903.
13. Koivunen J.P., Mermel C., Zejnullahu K., Murphy C., Lifshits E., Holmes A.J., et al. EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer. Clin Cancer Res 2008, 14:4275-4283.
14. Rodig S.J., Mino-Kenudson M., Dacic S., Yeap B.Y., Shaw A., Barletta J.A., et al. Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population. Clin Cancer Res 2009, 15:5216-5223.